ReviewJapanese journal of radiology2025
Noninvasive dynamic vascular imaging: arterial spin labeling-based noncontrast magnetic resonance digital subtraction angiography for cerebral disease diagnoses.
Review in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Molecular and multimodal biomarkers in Moyamoya disease: from pathogenic mechanisms to clinical translation.European journal of medical research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Digital subtraction angiography (DSA) is the gold standard for assessing cerebrovascular hemodynamics. DSA is predominantly utilized to evaluate the hemodynamic information of various cerebral diseases. However, DSA is relatively invasive and involves radiation exposure and risks of allergic reactions or renal dysfunction related to iodine-based contrast agents. Magnetic resonance DSA (MRDSA) with a gadolinium-based contrast agent is a popular method for assessing hemodynamics without radiation exposure. However, it has the disadvantage of the risk of allergy due to the contrast agent and lower temporal and spatial resolution than DSA. In recent years, arterial spin labeling-based noncontrast MRDSA (ASL-MRDSA), which utilizes blood labeled with radiofrequency pulses as an endogenous tracer, has been developed. ASL-MRDSA exhibits the same temporal resolution as DSA; therefore, it can yield dynamic information about various cerebral diseases. Pulsed ASL has been used as the major labeling method. However, the recent development of the pseudocontinuous ASL method has enabled high ASL signal maintenance even at delayed phases. This advancement allows for a more detailed assessment of hemodynamic information about vascular diseases, including major artery severe stenosis, occlusion, and moyamoya disease. Furthermore, combining it with superselective labeling pulses also allows for a more detailed hemodynamic assessment of complex vascular malformations such as DSA. In addition, ASL-MRDSA using ultrashort-echo time can acquire signals before phase dispersion occurs, which reduces artifacts induced by metallic materials and blood flow. This technique is useful for assessing post-clipping, post-coiling, and pseudostenosis. Furthermore, ASL-MRDSA using a wheel scan mode without full sampling achieves higher temporal resolution than DSA, which enables blood flow evaluation within giant cerebral aneurysms. Herein, we introduce the basic principles and various novel techniques of ASL-MRDSA and demonstrate its clinical applications, pitfalls, and limitations in cerebral disease diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.